CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delfino, D. V.
Right arrow Articles by Riccardi, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delfino, D. V.
Right arrow Articles by Riccardi, C.
Cell Growth & Differentiation Vol. 12, 51-60, January 2001
© 2001 American Association for Cancer Research


Articles

Differentiation of Ly49s-positive or -negative Natural Killer Cells Is Inhibited by Anti-H-2b Monoclonal Antibodies Acting at the Level of Bone Marrow Progenitors from B6 Mice1

Domenico V. Delfino2, Margarita Salcedo, Barbara Di Marco, Emira Ayroldi, Giuseppe Nocentini, Stefano Bruscoli, Luigi Brunetti, Hans-Gustaf Ljunggren and Carlo Riccardi

Department of Clinical and Experimental Medicine, Section of Pharmacology, University of Perugia, 06100 Perugia, Italy [D. V. D., B. D. M., E. A., G. N., S. B., C. R.]; Karolinska Institute MTC, Stockholm, Sweden [M. S., H-G. L.]; and Department Scienza del Farmaco, University G. D’Annunzio, 66100 Chieti, Italy [L. B.]

Abstract

To investigate the role of MHC class I on in vitro differentiation of natural killer (NK) cells, a CD44low/-CD2-classIlow population was isolated from mouse bone marrow. This population, which lacked expression of NK-1.1, Ly49A, Ly49C/I, and Ly49G, generated populations of NK-1.1+ NK cells expressing Ly49A, Ly49C/I, or Ly49G when cocultured for 13 days with syngeneic supportive stromal cells in the presence of interleukin 2. Ly49A and Ly49C/I were absent on the progeny of progenitors tested after 7 days of culture but were expressed as a late event together with low-level expression of NK-1.1, from day 8 of culture. The addition of anti-H-2b monoclonal antibody to cultures at day 0 inhibited proliferation of progenitors supported by either syngeneic, allogeneic, or H-2b-deficient stromal cells, thus suggesting that the effect was not exerted on stromal cells. Additional analyses demonstrated that class Ilow progenitors generated class I+ cells on which the anti-H-2b monoclonal antibody exerted its inhibitory effect.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2001 by the American Association of Cancer Research.